FDA
label_change
· 2015-10-06
FDA Approved: MAXITROL — Supplemental Application (Novartis Pharmaceuticals Corporation)
Summary
FDA approved a supplemental application for MAXITROL from Novartis Pharmaceuticals Corporation to update labeling for the combination ophthalmic product contain…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for MAXITROL (NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE)